Nuvation Bio (NUVB) Gross Profit (2024 - 2026)

Nuvation Bio (NUVB) posted quarterly Gross Profit of $82.9 million for Q1 2026, up 8268.99% year-over-year from $990000.0 in Q1 2025, and up 68.99% quarter-over-quarter from $49.0 million in Q4 2025.

Nuvation Bio (NUVB) Gross Profit (2024 - 2026) Analysis & Trends

Nuvation Bio (NUVB) has reported Gross Profit for 3 consecutive years, with $82.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Gross Profit rose 8268.99% year-over-year to $82.9 million; the TTM figure through Mar 2026 stood at $143.9 million (up 7962.13% YoY), while the FY2025 annual figure was $62.0 million, up 7704.53% from the prior year.
  • Gross Profit improved to $82.9 million in Q1 2026 per NUVB's latest filing, from $49.0 million in the prior quarter.
  • Across five years, Gross Profit topped out at $82.9 million in Q1 2026 and bottomed at -$788000.0 in Q3 2024.
  • Historically, Gross Profit has averaged $18.2 million across 3 years, with a median of $1.9 million in 2024.
  • Annual changes were most pronounced in 2025 — Gross Profit soared 1339.97% — and 2026, when it soared 8268.99%.
  • Nuvation Bio's Gross Profit stood at $1.5 million in 2024, then soared by 3179.46% to $49.0 million in 2025, then surged by 68.99% to $82.9 million in 2026.
  • Business Quant data shows NUVB's Gross Profit at $82.9 million in Q1 2026, $49.0 million in Q4 2025, and $9.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Nuvation Bio 2.16 Bn 2.16 Bn 30.78 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 30.78 Mn
Jun 30, 2026 30.78 Mn
Mar 31, 2026 82.85 Mn
Mar 31, 2026 82.85 Mn
Dec 31, 2025 49.03 Mn
Dec 31, 2025 49.03 Mn
Sep 30, 2025 9.77 Mn
Sep 30, 2025 9.77 Mn
Jun 30, 2025 2.26 Mn
Jun 30, 2025 2.26 Mn
Mar 31, 2025 990,000.00
Mar 31, 2025 990,000.00
Dec 31, 2024 1.50 Mn
Dec 31, 2024 1.50 Mn
Sep 30, 2024 -788,000.00
Sep 30, 2024 -788,000.00
Jun 30, 2024 88,000.00
Jun 30, 2024 88,000.00